Similarly, in non-AD mice, subchronic intracerebroventricular injection of CCL3 resulted in inhibition of LTP and cognitive deficits, processes mediated by CCR5, as its antagonist abolished these effects (Marciniak et al. 2015). The gene discussed is CCL3; the disease is Alzheimer disease.